Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Boosted by Goelzer Investment Management Inc.

Goelzer Investment Management Inc. lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.6% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,321 shares of the medical equipment provider’s stock after acquiring an additional 39 shares during the period. Goelzer Investment Management Inc.’s holdings in Intuitive Surgical were worth $3,105,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. J. W. Coons Advisors LLC grew its holdings in shares of Intuitive Surgical by 6.0% during the fourth quarter. J. W. Coons Advisors LLC now owns 1,170 shares of the medical equipment provider’s stock valued at $395,000 after buying an additional 66 shares in the last quarter. Oppenheimer & Co. Inc. increased its holdings in shares of Intuitive Surgical by 13.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 13,902 shares of the medical equipment provider’s stock valued at $4,690,000 after purchasing an additional 1,597 shares during the period. Cetera Advisor Networks LLC increased its holdings in shares of Intuitive Surgical by 22.7% in the 4th quarter. Cetera Advisor Networks LLC now owns 35,285 shares of the medical equipment provider’s stock valued at $11,904,000 after purchasing an additional 6,517 shares during the period. Envestnet Asset Management Inc. lifted its position in shares of Intuitive Surgical by 17.2% in the fourth quarter. Envestnet Asset Management Inc. now owns 628,630 shares of the medical equipment provider’s stock worth $212,075,000 after purchasing an additional 92,262 shares in the last quarter. Finally, Morningstar Investment Services LLC purchased a new position in Intuitive Surgical during the fourth quarter valued at approximately $499,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 2,943 shares of Intuitive Surgical stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the sale, the senior vice president now directly owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the sale, the director now directly owns 12,275 shares in the company, valued at approximately $5,441,507.50. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 53,120 shares of company stock worth $25,528,753 over the last three months. Company insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG traded up $2.32 on Friday, reaching $481.95. 903,893 shares of the stock traded hands, compared to its average volume of 1,479,332. The firm has a market cap of $170.95 billion, a price-to-earnings ratio of 86.99, a P/E/G ratio of 5.39 and a beta of 1.39. The stock’s 50-day moving average price is $476.55 and its 200-day moving average price is $431.54. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $496.48.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. The firm’s revenue for the quarter was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.18 earnings per share. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on ISRG shares. BTIG Research lifted their target price on shares of Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research note on Wednesday, August 28th. Evercore ISI upped their target price on Intuitive Surgical from $410.00 to $475.00 and gave the stock an “in-line” rating in a research report on Tuesday. Citigroup raised their price target on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Robert W. Baird raised their price objective on shares of Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. Finally, Piper Sandler boosted their target price on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an “overweight” rating in a research report on Friday, July 19th. Six research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus price target of $449.70.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.